Impact of Novel Low-Density Lipoprotein-Cholesterol Assessment on the Utility of Secondary Non-High-Density Lipoprotein-C and Apolipoprotein B Targets in Selected Worldwide Dyslipidemia Guidelines | Zendy

Vasanth Sathiyakumar | Zendy; Jihwan Park | Zendy; Renato Quispe | Zendy; Mohamed B. Elshazly | Zendy; Erin D. Michos | Zendy; Maciej Banach | Zendy; Peter P. Tóth | Zendy; Seamus P. Whelton | Zendy; Roger S. Blumenthal | Zendy; Steven R. Jones | Zendy; Seth S. Martin | Zendy

Open Access

Impact of Novel Low-Density Lipoprotein-Cholesterol Assessment on the Utility of Secondary Non-High-Density Lipoprotein-C and Apolipoprotein B Targets in Selected Worldwide Dyslipidemia Guidelines

Author(s) -

Vasanth Sathiyakumar,

Jihwan Park,

Renato Quispe,

Mohamed B. Elshazly,

Erin D. Michos,

Maciej Banach,

Peter P. Tóth,

Seamus P. Whelton,

Roger S. Blumenthal,

Steven R. Jones,

Seth S. Martin

Publication year - 2018

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.117.032463

Subject(s) - apolipoprotein b , dyslipidemia , medicine , guideline , lipoprotein , diabetes mellitus , population , cholesterol , metabolic syndrome , national health and nutrition examination survey , endocrinology , gastroenterology , pathology , environmental health

Selected dyslipidemia guidelines recommend non-high-density lipoprotein-cholesterol (non-HDL-C) and apolipoprotein B (apoB) as secondary targets to the primary target of low-density lipoprotein-cholesterol (LDL-C). After considering 2 LDL-C estimates that differ in accuracy, we examined: (1) how frequently non-HDL-C guideline targets could change management; and (2) the utility of apoB targets after meeting LDL-C and non-HDL-C targets.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research